arrow_back Back Filing freshness 10-Q SEC EDGAR

Hemab Therapeutics Holdings, Inc.

COAG
$45.54 ▲ +0.44 (+0.96%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
0 Visible periods
0 Metrics
Peer-ranked Benchmarks
Price Chart
insights
Verdict pending

Sync financial data to generate a health grade for this company.

auto_awesome

Analytical Summary

Review the statement evidence below to form a view on COAG.

Market Cap —
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC —
FCF / Share —
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago